UnitedHealth earnings report

Note: This section contains information in English only.
Source: Dukascopy Bank SA
UnitedHealth Group (UHG) reported strong Q1 2025 revenue growth but earnings slightly below expectations due to higher Medicare-related care costs and changes in Optum Health member profiles. Total revenues reached $109.6 billion, up $9.8 billion year-over-year. Net earnings were $6.85 per share, with adjusted earnings of $7.20 per share. The consolidated operating margin was 8.3%, the medical care ratio was 84.8%, and the operating cost ratio improved to 12.4%. Cash flows from operations were $5.5 billion, and the company returned about $5 billion to shareholders through dividends and share repurchases.

For the full year 2025, UHG revised its outlook, projecting net earnings of $24.65 to $25.15 per share and adjusted earnings of $26.00 to $26.50 per share. The revision reflects higher-than-expected Medicare Advantage activity and changes in Optum Health member profiles, which management believes are addressable and expects to resolve over the course of the year.



By segment, UnitedHealthcare reported Q1 revenues of $84.6 billion and operating earnings of $5.2 billion, with total consumers served increasing by 780,000. Optum posted Q1 revenues of $63.9 billion and operating earnings of $3.9 billion. Within Optum, Optum Health revenues were $25.3 billion, impacted by member profile changes, Optum Rx revenues were $35.1 billion with 408 million adjusted scripts, and Optum Insight revenues reached $4.6 billion with a backlog of $32.9 billion, launching new AI-powered claims processing tools.
Back to articles

Actual Topics

Thu, 30 Oct 2025 14:45:09 GMT

Microsoft earnings report

Microsoft reported strong results for the first quarter of fiscal year 2026, ended September 30, 2025, with growth driven by its cloud and artificial intelligence businesses. Revenue reached $77.7 billion, up 18% from the same quarter last year, while operating income rose 24% to $38 billion. Net income totaled $27.7 billion, an increase of 12% on a GAAP basis and

Tue, 28 Oct 2025 10:45:04 GMT

Salvatore Ferragamo Group analysis

Salvatore Ferragamo Group designs, produces, and distributes luxury goods for men and women, including shoes, leather goods, apparel, and accessories. Its main focus remains on footwear and leather goods, supported by licensed products such as eyewear, watches, and fragrances. The brand sells through directly operated stores, online boutiques, and select wholesale partners. Salvatore Ferragamo's results for the nine months to

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Chcete-li se dozvědět více o platformě Dukascopy Bank CFD / Forex, SWFX a dalších souvisejících obchodních informacích, prosím, zavolejte nám, nebo vám můžeme zavolat my.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.